CME: Offering mifepristone as an abortion option
February 1st 2001While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.
Cover Story: Antepartum and intrapartum risk factors for newborn encephalopathy
February 1st 2001Many obstetric malpractice cases focus on fixing the blame for disturbed neurological function in the first days of an infant's life. Results of recent case-control studies, described here by the authors, question the traditional thinking that most of the risk factors are in the intrapartum period.